Published in Oncogene on August 24, 2009
Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene (2011) 1.26
PP2A-Mediated Anticancer Therapy. Gastroenterol Res Pract (2013) 1.01
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease. Future Med Chem (2011) 0.98
Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharmacol Sci (2011) 0.94
Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. PLoS One (2012) 0.91
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells. Breast Cancer Res (2014) 0.89
Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells. Oncotarget (2016) 0.82
Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy. PLoS One (2013) 0.82
miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells. J Cell Mol Med (2016) 0.80
Cardamonin Suppresses TGF-β1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A Expression. Biomol Ther (Seoul) (2015) 0.75
PI3K pathway alterations in cancer: variations on a theme. Oncogene (2008) 9.94
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J (2001) 9.40
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med (2002) 5.79
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem (2005) 5.62
Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A (2000) 4.55
Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem (2002) 4.14
Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta (2008) 3.74
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science (1992) 3.64
Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci U S A (1996) 3.50
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets (2008) 3.36
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res (2007) 3.15
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene (2007) 2.31
Fibronectin, integrins, and growth control. J Cell Physiol (2001) 2.14
The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell (2007) 2.10
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem (2003) 2.06
Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol (2006) 2.00
Nrf2 as a novel molecular target for chemoprevention. Cancer Lett (2004) 1.95
Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation (2008) 1.88
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med (2006) 1.81
Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol (2004) 1.75
Metastasis and AKT activation. Cell Cycle (2008) 1.68
Structural mechanism of demethylation and inactivation of protein phosphatase 2A. Cell (2008) 1.67
Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry (1995) 1.63
The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev (2003) 1.59
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res (2001) 1.51
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst (2002) 1.50
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br J Pharmacol (2003) 1.48
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias. Cancer Metastasis Rev (2008) 1.37
Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal (2002) 1.35
Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J Biol Chem (2007) 1.35
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Mol Pharmacol (2006) 1.24
Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity. J Biol Chem (2007) 1.22
The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A. J Biol Chem (2006) 1.20
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. J Exp Med (2007) 1.15
A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J Pharmacol Exp Ther (2002) 1.15
A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev (2008) 1.14
Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol (2002) 1.12
Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol (2006) 1.06
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol (2007) 1.03
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor. Mol Pharmacol (2006) 0.99
Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival. Oncogene (2006) 0.99
Dithiolethiones for cancer chemoprevention: where do we stand? Mol Cancer Ther (2008) 0.98
Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway. Hepatology (2007) 0.85
Non-steroidal anti-inflammatory drugs in cancer prevention and therapy. Anticancer Res (2007) 0.83
In vivo radioprotective effects of oltipraz in gamma-irradiated mice. Biochem Pharmacol (1998) 0.81
Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci (1999) 0.81
Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction. Microvasc Res (2006) 0.81
A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide (2001) 6.48
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (1985) 4.47
Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A (1988) 3.83
Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature (1985) 3.53
"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol (1996) 3.34
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem (1991) 3.27
Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci (2001) 2.82
Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol (1997) 2.52
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys (1988) 2.49
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A (1989) 2.48
Autoxidation kinetics of aqueous nitric oxide. FEBS Lett (1993) 2.47
Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem (1995) 2.28
Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci (2000) 2.25
Recombinant human interleukin 1 alpha: purification and biological characterization. J Immunol (1986) 2.24
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res (1994) 2.20
Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. Biochemistry (1986) 2.20
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med (1995) 2.14
Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation (1999) 2.11
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science (1981) 2.07
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging (2006) 2.03
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol (1999) 1.93
The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem (1985) 1.90
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res (1997) 1.81
Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol (1987) 1.81
Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem (1989) 1.76
Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J (2001) 1.75
Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience (2010) 1.70
Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A (2001) 1.63
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci U S A (1999) 1.63
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res (2000) 1.58
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer (1994) 1.57
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol (1987) 1.56
Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest (1995) 1.55
Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res (1987) 1.53
Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem (1996) 1.53
Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem (2001) 1.47
In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry (2000) 1.46
Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene (1995) 1.46
The isolation of ecdysterone inducible genes by hybridization subtraction chromatography. Nucleic Acids Res (1981) 1.43
Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J Am Chem Soc (2001) 1.42
Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell (2000) 1.41
Effects of autonomic nervous system on gastric damage by ethanol in the rat. Dig Dis Sci (1989) 1.38
Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem (1993) 1.37
Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem (2000) 1.36
Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med (1999) 1.35
Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98. J Biol Chem (1999) 1.29
NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.27
Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. J Biol Chem (1992) 1.27
Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene (2011) 1.26
NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther (1997) 1.26
Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion. J Biol Chem (2000) 1.25
Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem (1996) 1.25
Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci U S A (1985) 1.25
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci (2008) 1.23
Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem (1996) 1.23
Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res (1999) 1.23
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Binding of elastin to Staphylococcus aureus. J Biol Chem (1991) 1.21
Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc Natl Acad Sci U S A (1992) 1.20
Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem (2001) 1.20
Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res (1993) 1.17
Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol (1996) 1.17
Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis (1994) 1.17
Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience (2009) 1.15
HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res (1993) 1.15
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem (2000) 1.14
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med (2001) 1.14
High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sci (1985) 1.14
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
In vivo radiation protection by nitric oxide modulation. Cancer Res (1994) 1.13
Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1. J Biol Chem (1999) 1.13
Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology (1996) 1.12
Neuromedin B is present in lung cancer cell lines. Cancer Res (1992) 1.11
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate. Arch Biochem Biophys (1999) 1.10
An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J Pharmacol Exp Ther (1991) 1.09
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2001) 1.09
Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys (1999) 1.09
Bombesin-like peptides in rat brain: quantitation and biochemical characterization. Biochem Biophys Res Commun (1979) 1.08
Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc Natl Acad Sci U S A (1999) 1.07
Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. J Pept Res (1997) 1.07
Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem (1999) 1.07
Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol (1996) 1.07
Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol (1995) 1.07
Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci U S A (2001) 1.06
H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol (2008) 1.05
The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans. J Biol Chem (1994) 1.05
Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. Life Sci (1998) 1.05
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol (2000) 1.04
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03